Kangstem Biotech Co., Ltd. 217730.KQ Stock
Kangstem Biotech Co., Ltd. Price Chart
Kangstem Biotech Co., Ltd. 217730.KQ Financial and Trading Overview
| Kangstem Biotech Co., Ltd. stock price | 2345 KRW |
| Previous Close | 3145 KRW |
| Open | 3160 KRW |
| Bid | 3145 KRW x 0 |
| Ask | 3240 KRW x 0 |
| Day's Range | 3145 - 3250 KRW |
| 52 Week Range | 2495 - 4295 KRW |
| Volume | 102.92K KRW |
| Avg. Volume | 160.09K KRW |
| Market Cap | 65.54B KRW |
| Beta (5Y Monthly) | -0.196335 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
217730.KQ Valuation Measures
| Enterprise Value | 91.82B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.24973 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.953 |
| Enterprise Value/EBITDA | -4.694 |
Trading Information
Kangstem Biotech Co., Ltd. Stock Price History
| Beta (5Y Monthly) | -0.196335 |
| 52-Week Change | 6.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4295 KRW |
| 52 Week Low | 2495 KRW |
| 50-Day Moving Average | 3154.5 KRW |
| 200-Day Moving Average | 3024.05 KRW |
217730.KQ Share Statistics
| Avg. Volume (3 month) | 160.09K KRW |
| Avg. Daily Volume (10-Days) | 233.83K KRW |
| Shares Outstanding | 20.84M |
| Float | 35.07M |
| Short Ratio | N/A |
| % Held by Insiders | 7.36% |
| % Held by Institutions | 0.61% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -147.23% |
| Operating Margin (ttm) | -151.96% |
| Gross Margin | 30.50% |
| EBITDA Margin | -126.84% |
Management Effectiveness
| Return on Assets (ttm) | -18.70% |
| Return on Equity (ttm) | -47.16% |
Income Statement
| Revenue (ttm) | 15.42B KRW |
| Revenue Per Share (ttm) | 413.77 KRW |
| Quarterly Revenue Growth (yoy) | -13.70% |
| Gross Profit (ttm) | 2.69B KRW |
| EBITDA | -19563005952 KRW |
| Net Income Avi to Common (ttm) | -22708705280 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 40.89B KRW |
| Total Cash Per Share (mrq) | 1077.69 KRW |
| Total Debt (mrq) | 13.17B KRW |
| Total Debt/Equity (mrq) | 23.12 KRW |
| Current Ratio (mrq) | 3.386 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20355979264 KRW |
| Levered Free Cash Flow (ttm) | -13814926336 KRW |
Profile of Kangstem Biotech Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Sinan Building |
| ZIP | N/A |
| Phone | 82 2 888 1590 |
| Website | https://www.kangstem.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Kangstem Biotech Co., Ltd., a biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases. The company's stem cell therapy products include Furestem-AD for treatment of subacute and chronic atopic dermatitis; Furestem-RA to treat rheumatoid arthritis; and Furestem-CD for treatment of active crohn's disease. It also provides stem cell conditioned media, such as umbilical cord blood-derived stem cell conditioned media that includes epidermal, vascular endothelium, keratinocyte, hepatocyte, transforming, and platelet-derived growth factors, as well as growth and differentiation factor 11, and Fibroblast growth factor 2 for skin growth and regeneration. In addition, the company offers stem cell culture media, including KSB-3 kit, a medium for culturing the human mesenchymal stem cell; and cell freezing and thawing platform. Further, it provides pharmaceutical contract manufacturing and development services. Kangstem Biotech Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.
Q&A For Kangstem Biotech Co., Ltd. Stock
What is a current 217730.KQ stock price?
Kangstem Biotech Co., Ltd. 217730.KQ stock price today per share is 2345 KRW.
How to purchase Kangstem Biotech Co., Ltd. stock?
You can buy 217730.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kangstem Biotech Co., Ltd.?
The stock symbol or ticker of Kangstem Biotech Co., Ltd. is 217730.KQ.
How many shares does Kangstem Biotech Co., Ltd. have in circulation?
The max supply of Kangstem Biotech Co., Ltd. shares is 20.84M.
What is Kangstem Biotech Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Kangstem Biotech Co., Ltd. PE Ratio is now.
What was Kangstem Biotech Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Kangstem Biotech Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Kangstem Biotech Co., Ltd. 217730.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Small Index KQSM | 2737.08 KRW 2.07 USD |
-1.29
|
354.59K KRW 268 USD | 2724.25 KRW 2.06 USD | 2751.73 KRW 2.08 USD | — - | 354.59K KRW 268 USD |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}